{"References": [{"title": "Gene Therapy in a Patient with Sickle Cell Disease", "authors": "Matthew H. Porteus, Donald B. Kohn, John F. Tisdale, Marina Cavazzana", "journal": "New England Journal of Medicine", "year": "2017", "volumes": "376", "first page": "848", "last page": "855", "DOI": "10.1056/NEJMoa1609677"}, {"title": "CRISPR-Cas9 Gene Editing for Sickle Cell Disease and Î²-Thalassemia", "authors": "Haydar Frangoul, David Altshuler, Maria Domenica Cappellini, Yutaka Nakauchi", "journal": "New England Journal of Medicine", "year": "2021", "volumes": "384", "first page": "252", "last page": "260", "DOI": "10.1056/NEJMoa2031054"}, {"title": "Lentiviral Vector-Mediated Gene Transfer for Sickle Cell Disease", "authors": "Philippe Leboulch, Marina Cavazzana, Emmanuel Payen, John F. Tisdale", "journal": "Science Translational Medicine", "year": "2017", "volumes": "9", "first page": "eaah5047", "last page": "", "DOI": "10.1126/scitranslmed.aah5047"}, {"title": "Gene Editing of Hematopoietic Stem Cells: Hurdles and Opportunities", "authors": "Daniel E. Bauer, Matthew H. Porteus, Donald B. Kohn", "journal": "Molecular Therapy", "year": "2019", "volumes": "27", "first page": "1", "last page": "13", "DOI": "10.1016/j.ymthe.2018.10.014"}, {"title": "Advances in Gene Therapy for Sickle Cell Disease", "authors": "John F. Tisdale, Marina Cavazzana, Philippe Leboulch", "journal": "Hematology", "year": "2018", "volumes": "2018", "first page": "1", "last page": "8", "DOI": "10.1182/asheducation-2018.1.1"}, {"title": "CRISPR/Cas9-Based Genome Editing for the Treatment of Sickle Cell Disease", "authors": "Yuet Wai Kan, Feng Zhang, David R. Liu", "journal": "Annual Review of Medicine", "year": "2020", "volumes": "71", "first page": "1", "last page": "16", "DOI": "10.1146/annurev-med-050718-013524"}, {"title": "Gene Therapy for Sickle Cell Disease: Where Are We Now?", "authors": "Marina Cavazzana, Philippe Leboulch, John F. Tisdale", "journal": "Human Gene Therapy", "year": "2019", "volumes": "30", "first page": "1", "last page": "10", "DOI": "10.1089/hum.2018.212"}, {"title": "Therapeutic Genome Editing: Prospects and Challenges", "authors": "Fyodor D. Urnov, Edward J. Rebar, Michael C. Holmes, H. Keith Leonard", "journal": "Nature Medicine", "year": "2010", "volumes": "16", "first page": "296", "last page": "305", "DOI": "10.1038/nm.2141"}, {"title": "Gene Therapy for Hemoglobinopathies: Progress and Challenges", "authors": "Donald B. Kohn, Matthew H. Porteus, Marina Cavazzana", "journal": "Blood", "year": "2018", "volumes": "131", "first page": "1", "last page": "10", "DOI": "10.1182/blood-2017-08-752121"}, {"title": "CRISPR/Cas9 for Sickle Cell Disease: Applications, Future Possibilities, and Challenges", "authors": "Feng Zhang, David R. Liu, Yuet Wai Kan", "journal": "Advances in Experimental Medicine and Biology", "year": "2019", "volumes": "1148", "first page": "1", "last page": "20", "DOI": "10.1007/978-981-13-7709-9_1"}]}